<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03876964</url>
  </required_header>
  <id_info>
    <org_study_id>JCU-001</org_study_id>
    <nct_id>NCT03876964</nct_id>
  </id_info>
  <brief_title>J-Valve Compassionate Use</brief_title>
  <official_title>J-Valve Compassionate Use Cases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>JC Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>JC Medical, Inc.</source>
  <brief_summary>
    <textblock>
      J-Valve TF Compassionate Use cases approved on a case by case basis by the FDA
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The J-Valve is designed to treat patients with aortic valve disease requiring replacement.
      There are certain patient subsets that the J-Valve TF is uniquely able to treat and where
      there are no good alternative treatments for patients at high surgical risk. Physicians have
      applied for individual approval to treat patients with the J-Valve in certain clinical
      conditions.
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <expanded_access_info>
    <expanded_access_type_individual>Yes</expanded_access_type_individual>
  </expanded_access_info>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Valve Insufficiency</condition>
  <condition>Aortic Valve Stenosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcatheter Aortic Valve Replacement</intervention_name>
    <description>Minimally invasive replacement of the aortic valve through a catheter.</description>
    <other_name>TAVR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Dennis M McMahon, MD</last_name>
    <phone>650-477-2781</phone>
    <phone_ext>7601</phone_ext>
    <email>dmcmahon@jcmedicalinc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chris Yang, PhD</last_name>
    <phone>650-477-2781</phone>
    <email>cyang@jcmedicalinc.com</email>
  </overall_contact_backup>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 13, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

